Delayed gastric emptying, potential aspiration risks, and medication interactions — learn the hospitalist’s approach to ...

Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved ...

Andy Cohen has revealed he took a small dose of a "revolutionary" GLP-1 weight loss drug over the summer and lost 25 pounds.

Lots of research suggests such medications must be used indefinitely to maintain weight loss and related health benefits. But ...

Findings from an international database seem encouraging but could be due to confounders or older GLP-1 receptor agonists.

Elevated levels of the gut hormone GLP-1 and its receptor may worsen brain inflammation and trigger severe symptoms in patients with neuromyelitis optica spectrum disorder (NMOSD), suggesting GLP-1 ...

GLP-1 weight loss drugs like Ozempic and Mounjaro are booming, but their impact on gut health is raising critical questions.

Initially marketed as diabetes treatments, GLP-1 drugs are now surging in popularity as weight loss solutions. With more ...

GLP-1 receptor agonists may reduce the likelihood of mortality and increase odds for transplant wait-listing for patients ...

Novo Nordisk reported results from its phase 3 clinical trial for its experimental obesity drug cagrilintide which showed significant weight loss among participants. The research, presented at the ...

The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like ...

Medical experts discuss whether GLP-1 medications, including Mounjaro and Zepbound, could become comprehensive treatments for ...